# Verrica Pharmaceuticals Inc.: Form 8-K, filed Jun 14, 2022

- Company: [Verrica Pharmaceuticals Inc.](/companies/vrca.md) (CIK 1660334)
- Form: 8-K
- Filed: 2022-06-14
- Accepted by EDGAR: Jun 14, 2022, 16:31 ET
- Period: 2022-06-09
- Accession: 0001193125-22-173863
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1660334/000119312522173863/d358749d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1660334/000119312522173863/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1660334/000119312522173863/d358749d8k.htm

Filed Jun 14, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-173863. Last ingested by Listed: Nov 14, 2026, 20:18 ET. No prices; not investment advice.
